|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 17945 |
FusionGeneSummary for ITPR1_SOCS7 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ITPR1_SOCS7 | Fusion gene ID: 17945 | Hgene | Tgene | Gene symbol | ITPR1 | SOCS7 | Gene ID | 3708 | 122809 |
| Gene name | inositol 1,4,5-trisphosphate receptor type 1 | suppressor of cytokine signaling 4 | |
| Synonyms | ACV|CLA4|INSP3R1|IP3R|IP3R1|PPP1R94|SCA15|SCA16|SCA29 | SOCS7 | |
| Cytomap | 3p26.1 | 14q22.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | inositol 1,4,5-trisphosphate receptor type 1IP3 receptorIP3R 1inositol 1,4,5-triphosphate receptor, type 1protein phosphatase 1, regulatory subunit 94type 1 InsP3 receptortype 1 inositol 1,4,5-trisphosphate receptor | suppressor of cytokine signaling 4SH2 domain containing SOCS box proteinSOCS-4SOCS-7suppressor of cytokine signaling 7 | |
| Modification date | 20180523 | 20180519 | |
| UniProtAcc | Q14643 | O14512 | |
| Ensembl transtripts involved in fusion gene | ENST00000302640, ENST00000354582, ENST00000423119, ENST00000456211, ENST00000357086, ENST00000544951, ENST00000443694, ENST00000463980, | ENST00000331159, ENST00000577233, | |
| Fusion gene scores | * DoF score | 7 X 10 X 6=420 | 3 X 4 X 2=24 |
| # samples | 11 | 5 | |
| ** MAII score | log2(11/420*10)=-1.93288580414146 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/24*10)=1.05889368905357 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: ITPR1 [Title/Abstract] AND SOCS7 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | ITPR1 | GO:0001666 | response to hypoxia | 19120137 |
| Hgene | ITPR1 | GO:0050849 | negative regulation of calcium-mediated signaling | 16793548 |
| Tgene | SOCS7 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity | 15590694 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | BF820643 | ITPR1 | chr3 | 4593932 | + | SOCS7 | chr17 | 36561397 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-intron | ENST00000302640 | ENST00000331159 | ITPR1 | chr3 | 4593932 | + | SOCS7 | chr17 | 36561397 | - |
| intron-intron | ENST00000302640 | ENST00000577233 | ITPR1 | chr3 | 4593932 | + | SOCS7 | chr17 | 36561397 | - |
| intron-intron | ENST00000354582 | ENST00000331159 | ITPR1 | chr3 | 4593932 | + | SOCS7 | chr17 | 36561397 | - |
| intron-intron | ENST00000354582 | ENST00000577233 | ITPR1 | chr3 | 4593932 | + | SOCS7 | chr17 | 36561397 | - |
| intron-intron | ENST00000423119 | ENST00000331159 | ITPR1 | chr3 | 4593932 | + | SOCS7 | chr17 | 36561397 | - |
| intron-intron | ENST00000423119 | ENST00000577233 | ITPR1 | chr3 | 4593932 | + | SOCS7 | chr17 | 36561397 | - |
| intron-intron | ENST00000456211 | ENST00000331159 | ITPR1 | chr3 | 4593932 | + | SOCS7 | chr17 | 36561397 | - |
| intron-intron | ENST00000456211 | ENST00000577233 | ITPR1 | chr3 | 4593932 | + | SOCS7 | chr17 | 36561397 | - |
| intron-intron | ENST00000357086 | ENST00000331159 | ITPR1 | chr3 | 4593932 | + | SOCS7 | chr17 | 36561397 | - |
| intron-intron | ENST00000357086 | ENST00000577233 | ITPR1 | chr3 | 4593932 | + | SOCS7 | chr17 | 36561397 | - |
| intron-intron | ENST00000544951 | ENST00000331159 | ITPR1 | chr3 | 4593932 | + | SOCS7 | chr17 | 36561397 | - |
| intron-intron | ENST00000544951 | ENST00000577233 | ITPR1 | chr3 | 4593932 | + | SOCS7 | chr17 | 36561397 | - |
| intron-intron | ENST00000443694 | ENST00000331159 | ITPR1 | chr3 | 4593932 | + | SOCS7 | chr17 | 36561397 | - |
| intron-intron | ENST00000443694 | ENST00000577233 | ITPR1 | chr3 | 4593932 | + | SOCS7 | chr17 | 36561397 | - |
| intron-intron | ENST00000463980 | ENST00000331159 | ITPR1 | chr3 | 4593932 | + | SOCS7 | chr17 | 36561397 | - |
| intron-intron | ENST00000463980 | ENST00000577233 | ITPR1 | chr3 | 4593932 | + | SOCS7 | chr17 | 36561397 | - |
Top |
FusionProtFeatures for ITPR1_SOCS7 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ITPR1 | SOCS7 |
| Intracellular channel that mediates calcium release fromthe endoplasmic reticulum following stimulation by inositol 1,4,5-trisphosphate (PubMed:27108797). Involved in the regulation ofepithelial secretion of electrolytes and fluid through theinteraction with AHCYL1 (By similarity). Plays a role in ERstress-induced apoptosis. Cytoplasmic calcium released from the ERtriggers apoptosis by the activation of CaM kinase II, eventuallyleading to the activation of downstream apoptosis pathways (Bysimilarity). {ECO:0000250|UniProtKB:P11881,ECO:0000269|PubMed:27108797}. | Regulates signaling cascades probably through proteinubiquitination and/or sequestration. Functions in insulinsignaling and glucose homeostasis through IRS1 ubiquitination andsubsequent proteasomal degradation. Inhibits also prolactin,growth hormone and leptin signaling by preventing STAT3 and STAT5activation, sequestering them in the cytoplasm and reducing theirbinding to DNA. May be a substrate recognition component of a SCF-like E3 ubiquitin-protein ligase complex which mediates theubiquitination and subsequent proteasomal degradation of targetproteins (By similarity). {ECO:0000250,ECO:0000269|PubMed:15677474, ECO:0000269|PubMed:16127460}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ITPR1_SOCS7 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ITPR1_SOCS7 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ITPR1_SOCS7 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | ITPR1 | Q14643 | DB00201 | Caffeine | Inositol 1,4,5-trisphosphate receptor type 1 | small molecule | approved |
| Hgene | ITPR1 | Q14643 | DB09462 | Glycerin | Inositol 1,4,5-trisphosphate receptor type 1 | small molecule | approved|investigational |
Top |
RelatedDiseases for ITPR1_SOCS7 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | ITPR1 | C0005586 | Bipolar Disorder | 2 | PSYGENET |
| Hgene | ITPR1 | C0431401 | Gillespie syndrome | 2 | ORPHANET;UNIPROT |
| Hgene | ITPR1 | C1847725 | SPINOCEREBELLAR ATAXIA 15 | 2 | CTD_human;ORPHANET;UNIPROT |
| Hgene | ITPR1 | C1861732 | SPINOCEREBELLAR ATAXIA 29 | 2 | CTD_human;ORPHANET;UNIPROT |
| Hgene | ITPR1 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| Hgene | ITPR1 | C1527348 | Brain Hypoxia | 1 | CTD_human |
| Hgene | ITPR1 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|